NOVEL TREATMENTS FOR NEUROMUSCULAR DISORDERS Flex Pharma, Inc. is a biotechnology company that is developing innovative and proprietary treatments for nocturnal leg cramps, cramps and spasms associated with severe neuromuscular conditions such as ALS and MS, and exercise-associated muscle cramps. SPOTLIGHT September 13, 2016 Flex Pharma Initiates Phase 2 Efficacy Study in Amyotrophic Lateral Sclerosis Read More September 1, 2016 Flex Pharma Presenting at Upcoming Investor Conferences in September 2016 Read More Terms of Use Privacy Policy Sitemap Contact © 2016 FlexPharma